Kimberly-Clark/$KMB

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Kimberly-Clark

With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.

Ticker

$KMB
Primary listing

Employees

38,000

Kimberly-Clark Metrics

BasicAdvanced
$41B
16.97
$7.26
0.33
$3.74
4.09%

What the Analysts think about Kimberly-Clark

Analyst ratings (Buy, Hold, Sell) for Kimberly-Clark stock.

Bulls say / Bears say

Second-quarter organic sales rose 3.9%, driven by a 5% increase in volume—its strongest volume growth in five years—highlighting the effectiveness of its revenue growth management strategy (Reuters).
Following Q2 performance, the company raised its 2025 profit forecast to low- to mid-single-digit adjusted EPS growth, reflecting confidence in sustained volume-led momentum and streamlined operations (Reuters).
In June 2025, Kimberly-Clark agreed to sell a 51% stake in its international tissue unit to Suzano for $3.4 billion, unlocking $1.73 billion in cash to refocus on higher-margin personal care and North American tissue segments (Reuters).
Q2 net sales from continuing operations fell 1.6% year-over-year to $4.16 billion, weighed by a 4.4% impact from the divestiture of its PPE business and a 1.0% foreign currency headwind (Reuters).
The company anticipates approximately $170 million in incremental tariff-related costs for 2025, exposing margins to further geopolitical trade risks despite recent reductions (Reuters).
In April 2025, Kimberly-Clark cut its full-year 2025 profit forecast to flat-to-positive adjusted EPS growth, down from prior mid-to-high single-digit expectations, citing rising supply chain costs and tariff pressures (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 1 Oct 2025.

Kimberly-Clark Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Kimberly-Clark Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $KMB

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs